相关实验视频
Updated: May 16, 2025
06:03
Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
9.0K
RNA疗法在治疗心血管疾病方面的潜力
Gayatri Mainkar1,2,3,4, Matteo Ghiringhelli1,2,3, Lior Zangi5,6,7
1Icahn School of Medicine at Mount Sinai, Cardiovascular Research Institute, New York, NY, 10029, USA.
Drugs
|April 2, 2025
概括
RNA疗法为心血管疾病 (CVD) 提供了新的希望,因为它针对的是根本原因,而不仅仅是症状. 本综述探讨了针对各种心血管疾病病理的基于RNA的治疗方法及其传递策略.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 尽管医学的进步,心血管疾病 (CVD) 仍然是全球领先的健康负担.
- 目前的治疗方法往往控制症状,而不是解决潜在原因.
- 新的治疗策略对于有效应对心血管疾病至关重要.
研究的目的:
- 审查目前基于RNA的治疗心血管疾病 (CVD) 的现状.
- 讨论在心血管疾病中RNA治疗的分类,作用机制和输送策略.
- 突出潜在的CVD目标,可接受基于RNA的干预.
主要方法:
- 对基于RNA的治疗策略进行文献综述.
- 分析不同类型的RNA分子及其在基因表达调节中的功能.
- 检查RNA治疗的输送系统的进步.
- 确定特定的心血管疾病病理和基于RNA的治疗点.
主要成果:
- RNA疗法可以解决各种心血管疾病机制,包括重血管化,再生,亡预防,降脂,血压控制,纤维化逆转和遗传纠正.
- 各种RNA模式显示出治疗一系列心血管疾病的前景.
- 传递策略对于基于RNA的心血管疾病治疗的临床实施至关重要.
结论:
- 基于RNA的疗法代表了治疗心血管疾病的前沿,通过准根本的因果途径来治疗心血管疾病.
- RNA分子的多功能性允许在各种CVD环境中进行量身定制的干预.
- 在传递技术方面进行进一步的研究和开发对于实现RNA疗法在心脏病学中的全部潜力至关重要.
相关概念视频
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
02:30siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
1.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
409
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
409
01:20Types of RNA
5.5K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.5K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
38
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38